Skip to main content

Recombinant DNA Technology to Revolutionize the Biotechnology Sector with Major Players Involved during 2019-2027

Press release   •   Feb 02, 2019 16:55 IST

Rapid technological advancements in in genetic engineering and biotechnology techniques is expected to fuel the growth of the recombinant DNA technology market during the forecast period. In addition, increasing R&D expenditure and initiatives undertaken by market players for development of novel products is further expected to promote the growth of recombinant DNA technology market over the coming years. Moreover, development of products at lower costs is anticipated to offer growth opportunities in the recombinant DNA technology market.

Request a sample of this premium report at:

Some of the key players operating in the recombinant DNA technology market include,Thermo Fisher Scientific, Inc., Biogen, Sanofi, Merck KGaA, Pfizer, Inc., Amgen Inc., Monsanto Company, F. Hoffmann-La Roche, Novo Nordisk A/S, and GenScript among others.

Global Recombinant DNA Technology Market which has been compiled after an in-depth analysis of the market trends prevailing across five geographies (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America). Various segments of the market such as type/components/ application/industry verticals/ end-users are analyzed with robust research methodology which includes three step process starting with extensive secondary research to gather data from company profiles, global/regional associations, trade journals, technical white papers, paid databases etc. followed by primary research (interviews) with industry experts/KOLs to gain their insights and views on current scenarios and future scope of the market as well as validating the secondary information, further internal statistical model is used to estimate the market size and forecasts till 2027.

Recombinant DNA Technology also known as rDNA technology is a process that involves joining of DNA molecules from different sources and inserting them into host organism that helps to produce products for human use. rDNA end products are used in science, medicine, agriculture and industry. This technology has led to transfer of desired characteristics that are used to improve the existing systems by controlling expression of target genes.

Request a discount on standard prices of this premium report at:

Recombinant DNA Technology Market – Global Analysis to 2027 is an expert compiled study which provides a holistic view of the market covering current trends and future scope with respect to product/service, the report also covers competitive analysis to understand the presence of key vendors in the companies by analyzing their product/services, key financial facts, details SWOT analysis and key development in last three years. Further chapter such as industry landscape and competitive landscape provides the reader with recent company level insights covering mergers and acquisitions, joint ventures, collaborations, new product developments/strategies taking place across the ecosystem. The chapters also evaluate the key vendors by mapping all the relevant products and services to exhibit the ranking/position of top 5 key vendors.

Table of Content:
Chapter 1. Methodology
Chapter 2. Executive Summary
Chapter 3. Recombinant DNA Technology Industry Insights
Chapter 4. Recombinant DNA Technology Market, By Technology
Chapter 5. Recombinant DNA Technology Market, By End-user
Chapter 6. Recombinant DNA Technology Market, By Region
Chapter 7. Company Profiles

If You want to Purchase the Report Directly:

About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services.

Contact Us:

Call: +1-646-491-9876


Comments (0)

Add comment


By submitting the comment you agree that your personal data will be processed according to Mynewsdesk's Privacy Policy.